title: Gefitinib potentiates myeloid cell differentiation by ATRA.
authors.forename: M B
authors.initials: MB
authors.lastname: Miranda
authors.forename: R
authors.initials: R
authors.lastname: Duan
authors.forename: S M
authors.initials: SM
authors.lastname: Thomas
authors.forename: J R
authors.initials: JR
authors.lastname: Grandis
authors.forename: R L
authors.initials: RL
authors.lastname: Redner
authors.forename: J E
authors.initials: JE
authors.lastname: Jones
authors.forename: D E
authors.initials: DE
authors.lastname: Johnson
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D001854:Bone Marrow Cells / Q000166:cytology / Q000187:drug effects*; D002454:Cell Differentiation / Q000187:drug effects*; D004357:Drug Synergism; D000077156:Gefitinib; D018922:HL-60 Cells; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000473:pathology*; D011799:Quinazolines / Q000494:pharmacology*; D014212:Tretinoin / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D014212:Tretinoin; D000077156:Gefitinib